1665PD - Preliminary efficacy of durvalumab plus tremelimumab in platinum-refractory/resistant ED-SCLC from arm A of the phase II BALTIC study
| Autor: | Bondarenko, I., Juan-Vidal, O., Pajkos, G., Kryzhanivska, A., Pápai Székely, Z., Vicente, D., Vynnychenko, I.O., Jones, S., Wang, Y., Jiang, H., Reinmuth, N. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|